Reference number : 236-2014-2015-Q3-00037, amendment number : , agreement type : G, recipient legal name : POTTER, Andrew, recipient country : CA, recipient province : SK, recipient city : Saskatoon, recipient postal code : S7N 5A2, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 485283.0, agreement start date : 2014-04-01, agreement end date : 2017-03-31, description english : Developing novel vaccines for respiratory syncytial virus and parainfluenza virus type 3, description french : Developing novel vaccines for respiratory syncytial virus and parainfluenza virus type 3, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2014-15 to 2016-17), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2014-15 à 2016-17), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada